138 related articles for article (PubMed ID: 34635180)
1. Diagnostic retinal biopsy in the management of secondary non-CNS vitreoretinal lymphoma masquerading as viral retinitis: a case report.
Rali A; Xu LT; Craven C; Cohen JB; Yeh S; Grossniklaus HE; O'Keefe GD
Int J Retina Vitreous; 2021 Oct; 7(1):58. PubMed ID: 34635180
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of primary vitreoretinal lymphoma masquerading infectious retinitis by retinal biopsy.
Nguyen NV; Khan F; Cannon A; Huang Y; Kim L; Xu R; Rishi P; Conrady CD; Greiner TC; Yuil-Valdes A; Yeh S
J Ophthalmic Inflamm Infect; 2024 Feb; 14(1):8. PubMed ID: 38324143
[TBL] [Abstract][Full Text] [Related]
3. Vitreoretinal lymphoma, secondary to non-CNS systemic lymphoma, masquerading as an infectious retinitis.
Reddy V; Winslow R; Cao JH; Robertson ZM; Chen B; Ufret-Vincenty RL
Am J Ophthalmol Case Rep; 2019 Dec; 16():100545. PubMed ID: 31468000
[TBL] [Abstract][Full Text] [Related]
4. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
[TBL] [Abstract][Full Text] [Related]
5. The use of anterior segment optical coherence tomography (ASOCT) in demonstrating recurrence of vitreoretinal lymphoma (VRL) in the anterior vitreous.
Diaconita V; Rihani H; Mares V; Nehemy MB; Bakri SJ; Pulido JS
Int J Retina Vitreous; 2019; 5():19. PubMed ID: 31452937
[TBL] [Abstract][Full Text] [Related]
6. Metastatic B-cell lymphoma masquerading as infectious retinitis and vasculitis.
Say EA; Knupp CL; Gertsch KR; Chavala SH
Oncol Lett; 2012 Jun; 3(6):1245-1248. PubMed ID: 22783426
[TBL] [Abstract][Full Text] [Related]
7. Curious case of bilateral non-resolving vitritis - Unmasking the masquerade on ultra-widefield imaging.
Delhiwala K
Indian J Ophthalmol; 2022 Apr; 70(4):1438-1439. PubMed ID: 35326082
[TBL] [Abstract][Full Text] [Related]
8. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
[TBL] [Abstract][Full Text] [Related]
9. Two cases of primary vitreoretinal lymphoma: a diagnostic challenge : The supporting role of multimodal imaging in the diagnosis of primary vitreoretinal lymphoma.
Morara M; Foschi F; Veronese C; Torrazza C; Bacci F; Stefoni V; Ciardella PA
Int Ophthalmol; 2018 Feb; 38(1):353-361. PubMed ID: 28039672
[TBL] [Abstract][Full Text] [Related]
10. Vitreoretinal lymphoma presenting as frosted branch angiitis in a patient with diffuse large B-cell lymphoma.
Andersen T; Miller CG; Xia T; Pulido JS; Brucker AJ; Maguire AM
Am J Ophthalmol Case Rep; 2023 Jun; 30():101838. PubMed ID: 37131529
[TBL] [Abstract][Full Text] [Related]
11. AN UNUSUAL CASE OF PRIMARY VITREORETINAL LYMPHOMA: A TRANSFORMED LYMPHOMA.
Ustaoglu M; Patel R; Wang W; Shah S; Barr C
Retin Cases Brief Rep; 2024 Mar; 18(2):181-183. PubMed ID: 36730965
[TBL] [Abstract][Full Text] [Related]
12. Clinical Features and Treatment Outcomes of Vitreoretinal Lymphoma according to Its Association with CNS Lymphoma.
Cho BJ; Kim DY; Park UC; Lee JY; Yoon YH; Yu HG
Ocul Immunol Inflamm; 2018; 26(3):365-371. PubMed ID: 29394118
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives.
Kaburaki T; Taoka K
Jpn J Ophthalmol; 2023 Jul; 67(4):363-381. PubMed ID: 37209195
[TBL] [Abstract][Full Text] [Related]
14. PRIMARY CENTRAL NERVOUS SYSTEM AND VITREORETINAL LYMPHOMA MIMICKING VIRAL RETINITIS IN A YOUNG PATIENT.
Mehta N; Scholle T; Chevez-Barrios P; Schefler AC; Weng CY
Retin Cases Brief Rep; 2023 Sep; 17(5):567-571. PubMed ID: 37643044
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive overview of diagnosis, imaging and treatment of vitreoretinal lymphoma.
Menean M; Giuffrè C; Cicinelli MV; Marchese A; Modorati G; Bandello F; Miserocchi E
Eur J Ophthalmol; 2023 Nov; ():11206721231211931. PubMed ID: 37956540
[TBL] [Abstract][Full Text] [Related]
16. Vitreoretinal lymphoma: changing trends in diagnosis and local treatment modalities at a single institution.
Turaka K; Bryan JS; De Souza S; Gordon AJ; Kwong HM; Ziemianski MC; Reddy R; Sell CH
Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):412-7. PubMed ID: 22995952
[TBL] [Abstract][Full Text] [Related]
17. Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.
Rishi P; Maitra P; Das K; Rishi E; Manchegowda PT
Int Ophthalmol; 2021 Aug; 41(8):2711-2722. PubMed ID: 33834345
[TBL] [Abstract][Full Text] [Related]
18. Vitreoretinal Lymphoma in a Patient with Rheumatoid Arthritis with a History of Methotrexate-associated Lymphoproliferative Disorders.
Kurisu N; Hiyama T; Harada Y; Fukushima N; Katsuya N; Ureshino H; Ichinohe T; Kiuchi Y
Ocul Immunol Inflamm; 2022 Nov; ():1-6. PubMed ID: 36395469
[TBL] [Abstract][Full Text] [Related]
19. Use of intravitreal rituximab and methotrexate in vitreoretinal lymphoma.
Rahhal-Ortuño M; Udaondo-Mirete P; Fernández-Santodomingo AS; Díaz-Llopis M
Eur J Ophthalmol; 2022 Jan; 32(1):NP199-NP202. PubMed ID: 32985253
[TBL] [Abstract][Full Text] [Related]
20. Primary Vitreoretinal Lymphoma Masquerading as Refractory Retinitis.
Zloto O; Elkader AE; Fabian ID; Vishnevskia-Dai V
Case Rep Ophthalmol; 2015; 6(3):345-50. PubMed ID: 26557084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]